Yüklüyor......
CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma
CD26, a 110-kDa transmembrane glycoprotein that is expressed on several tumor cells including malignant lymphoma, has been implicated in tumorigenesis: however, little is known regarding its role in multiple myeloma (MM). Recently, we identified CD26 expression on human osteoclasts (OCs) and demonst...
Kaydedildi:
| Yayımlandı: | Blood Cancer J |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Nature Publishing Group UK
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6197267/ https://ncbi.nlm.nih.gov/pubmed/30348967 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-018-0127-y |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|